{"name":"Jazz Pharmaceuticals","slug":"jazz-pharmaceuticals","ticker":"","exchange":"","domain":"jazzpharma.com","description":"","hq":"Ireland","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1989-01-01","label":"Clozaril first approved","drug":"Clozaril","drugSlug":"clozapine","type":"approval","sentiment":"positive"},{"date":"2020-01-01","label":"Zepzelca first approved","drug":"Zepzelca","drugSlug":"lurbinectedin","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-05-01","label":"Clozaril patent expiry (Formulation)","drug":"Clozaril","drugSlug":"clozapine","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Dociparstat","genericName":"Dociparstat","slug":"dociparstat","indication":"Other","status":"discontinued"},{"name":"Rapydan","genericName":"Rapydan","slug":"rapydan","indication":"Other","status":"marketed"},{"name":"Xyrem","genericName":"Xyrem","slug":"xyrem","indication":"Cataplexy and narcolepsy","status":"marketed"},{"name":"pegcrisantaspase","genericName":"pegcrisantaspase","slug":"pegcrisantaspase","indication":"Other","status":"phase_2"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Clozaril","genericName":"CLOZAPINE","slug":"clozapine","indication":"Suicidal Behavior in Schizoaffective Disorder","status":"marketed"},{"name":"Sativex","genericName":"Sativex","slug":"sativex","indication":"Muscle Spasticity due to Multiple Sclerosis","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Zepzelca","genericName":"Zepzelca","slug":"zepzelca","indication":"Small cell carcinoma of lung","status":"marketed"},{"name":"Zepzelca","genericName":"LURBINECTEDIN","slug":"lurbinectedin","indication":"Small cell carcinoma of lung","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Marinol","genericName":"Marinol","slug":"marinol","indication":"Anorexia from HIV","status":"marketed"}]},{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"ODSH at 0.125 mg/kg/h","genericName":"ODSH at 0.125 mg/kg/h","slug":"odsh-at-0-125-mg-kg-h","indication":"Protein-Losing Enteropathy Secondary to Single Ventricle","status":"discontinued"}]}],"pipeline":[{"name":"Dociparstat","genericName":"Dociparstat","slug":"dociparstat","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Clozaril","genericName":"CLOZAPINE","slug":"clozapine","phase":"marketed","mechanism":"Clozapine's efficacy in schizophrenia may be due to its antagonism of D2 and 5-HT2A receptors.","indications":["Suicidal Behavior in Schizoaffective Disorder","Suicidal Behavior in Schizophrenia","Treatment-Resistant Schizophrenia"],"catalyst":""},{"name":"Marinol","genericName":"Marinol","slug":"marinol","phase":"marketed","mechanism":"N-arachidonyl glycine receptor, Cannabinoid receptor 2, Fatty-acid amide hydrolase 1","indications":["Anorexia from HIV","Chemotherapy-induced nausea and vomiting"],"catalyst":""},{"name":"ODSH at 0.125 mg/kg/h","genericName":"ODSH at 0.125 mg/kg/h","slug":"odsh-at-0-125-mg-kg-h","phase":"discontinued","mechanism":"ODSH is a modified chitosan polymer that binds intestinal lymphatic proteins to reduce protein loss in enteropathy.","indications":["Protein-Losing Enteropathy Secondary to Single Ventricle"],"catalyst":""},{"name":"Rapydan","genericName":"Rapydan","slug":"rapydan","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Sativex","genericName":"Sativex","slug":"sativex","phase":"marketed","mechanism":"Small molecule","indications":["Muscle Spasticity due to Multiple Sclerosis"],"catalyst":""},{"name":"Xyrem","genericName":"Xyrem","slug":"xyrem","phase":"marketed","mechanism":"Calcium/calmodulin-dependent protein kinase type II subunit alpha, GABA-B receptor, Gamma-hydroxybutyrate receptor","indications":["Cataplexy and narcolepsy","Narcolepsy"],"catalyst":""},{"name":"Zepzelca","genericName":"Zepzelca","slug":"zepzelca","phase":"marketed","mechanism":"Small molecule","indications":["Small cell carcinoma of lung"],"catalyst":""},{"name":"Zepzelca","genericName":"LURBINECTEDIN","slug":"lurbinectedin","phase":"marketed","mechanism":"Zepzelca works by attaching an alkyl group to DNA, which interferes with DNA replication and causes cell death.","indications":["Small cell carcinoma of lung"],"catalyst":""},{"name":"pegcrisantaspase","genericName":"pegcrisantaspase","slug":"pegcrisantaspase","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPcDhQRWUtNGNSb1VPWm5UeEwwa3kzbWk5ZUhjc2dLOV9ldjZUdFhINzR0TGp2UFFTOEd5YzVUVzZqWmhEVXlnN2M5SUdOMUF5TmFKOFowQVRidXlVdTRjY2dvVllVbEpFbzVSZ2xCNmFmR3h4QlVmSnhZUGVQUEhSS3JGWjREWEhqTEx2dmJHSFI3ME4zemJvVHpZTkgwUXFxY254NmctSTUzMVpTZWFfc0o0QWZCSTExRXc?oc=5","date":"2026-04-03","type":"pipeline","source":"Stock Titan","summary":"Director at Jazz Pharmaceuticals (JAZZ) sells 6,000 company shares - Stock Titan","headline":"Director at Jazz Pharmaceuticals (JAZZ) sells 6,000 company shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOWE83akQ0T1dIWHN4dzA5b0xfVzhJakFTUjEwRkFGakxBM3FWQ2xuTFZEdzV4MFVMTVNFakFYaVdXck1ESkc4R3RMbWR3eEktWnprbG5ERThPUTlKV3RrejhGQ25QOUJ5cXFDLUZFZWpBSk94YzdvUXZOSFN4cG5IeGFMVzVnOFhiRTBnUEhmV2EtMWIwdW9IYzZOdG9fdlNLRkcwWVBTNmZHUlRYeFhhc3FfcURzbm8?oc=5","date":"2026-03-24","type":"pipeline","source":"Stock Titan","summary":"People with sleep disorders to get guidance on sodium, heart risk - Stock Titan","headline":"People with sleep disorders to get guidance on sodium, heart risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOVXFILTlxblVLajV3bkdvellyRU1mampZaHlyTDBHR1RmenRHdy1YTFU1Qkd3NzNTNUQ3NHIwaC1fZ0Y4a3VfMUN2YnM1cDNGcTBDRVNaRVVUOWtITmZDZFptS21NMjF1WF9BRkVzNHBkVlE1QXFOVXNCbmRTSFRGT25WcFE1ZkhmUkVYUWVBcUx1NVRmVVFv?oc=5","date":"2026-02-20","type":"earnings","source":"Statista","summary":"Total revenue of Jazz Pharmaceuticals from 2018 to 2024, by region - Statista","headline":"Total revenue of Jazz Pharmaceuticals from 2018 to 2024, by region","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPd0RJV2ZHcmZ0b284ZlIxTzQ2S3lRaWxoN1oxdk1qbTdmYTVoOFk0R2dqel9PdjZRbHFHdE9JOThoWC1xd2dHMlcwQUptZy1ub1NPMlhIUWFVWlpoRk1OdmstSC1YZGZSaHh0SXVrZjhpWjA2VFM3X3Y0dEFUTFB6b1JqODQyM055Q21XMmIyOC0yZmc2aC1zY0NNcFJVNHc?oc=5","date":"2026-02-20","type":"pipeline","source":"Statista","summary":"Number of employees at Jazz Pharmaceuticals from 2021 to 2024, by region - Statista","headline":"Number of employees at Jazz Pharmaceuticals from 2021 to 2024, by region","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQMGtGVzF4UFUxZ2ZlcnVPV2JXSGhybnR3UUgwX0R5OS1FdFlJZHRZWjluS25rY0V4RGxiUWtpaG93LWJkMzlHZ3I1a3k4LTBhcHNXVFR5THdvakZwTFJPRFc2ZmFGTktxNGlWQk9FT25Vc1F3WmxKTnFHOWJreVFpOFJIdEdlYy1OLVdnUjI2QnRHR3hUQnVaT3BSWHdQejFkYjROVlJySnFZWXpZNlBSd1RPVmhoemlOVi1SUFh2MXh3QQ?oc=5","date":"2026-02-17","type":"pipeline","source":"prnewswire.com","summary":"Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences - prnewswire.com","headline":"Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNRVQxbnlubWRERWlabUZUY2FfRGZqMER1akZ6ZEp2WVkzdVhhMUlQQ0trT1VTRjV3blJaU1llWjZpWGk2OFFUaHlWVEZhOTFoamxDMnRUOENSM0ZndmY4OTY3QkROUDZVNjF3NlJ2aGk0b1VtOXVtTndhQzZTM3o3STJDSFlsQWNyTWs2LW8ya2ZhOFltQnR2dU14QnpLYjk1NTVRUXNuT0lOaDFoRFE?oc=5","date":"2026-01-14","type":"pipeline","source":"Fierce Pharma","summary":"JPM26: Jazz's $200M voucher sale shows drumbeat of rising prices isn't stopping - Fierce Pharma","headline":"JPM26: Jazz's $200M voucher sale shows drumbeat of rising prices isn't stopping","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQeF84cWF2eDlBeXFLZnotTktNclRfXzhrX2lsSlNzanoyZFhmWEppYUZKYWFMQXgtTmMwakVxS3VhUmZySVJrR2hoU0t2OVZPeW5OM2Q3TU5MWnVwMFNIUmhIdWljTW1zZmZmZ1p4Y0w3WHJXbFhpd2ppb0pCRVowcTkwMHhlQllkdkI4b2hsbw?oc=5","date":"2026-01-10","type":"pipeline","source":"Yahoo Finance","summary":"Is Jazz Pharmaceuticals (JAZZ) Offering Value After Recent Pullback And 32.7% One Year Gain - Yahoo Finance","headline":"Is Jazz Pharmaceuticals (JAZZ) Offering Value After Recent Pullback And 32.7% One Year Gain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNT1FmRF9kcmgzczR2NkYxRldPTGN5SFdyanZpVWJsWE9xVXQ2SFdFNEt2WG0ycGxKbDF5UTBONHU1dElpZlRRaTNKbUxfM19jWDdCNmZsQm5EWW5Mb0VmYm5KQmZ4OWxoeDlEb2V3ajk0S1dwRmMyODRSYk9Ua1V4R2lmRVUzZms3Z3pVWVZrTXlFXzkxVWhEcXI3U0FSQjk2YnFadXhn?oc=5","date":"2026-01-09","type":"deal","source":"seekingalpha.com","summary":"Jazz Pharmaceuticals: A Strong Buy Due To Execution In Oncology (NASDAQ:JAZZ) - seekingalpha.com","headline":"Jazz Pharmaceuticals: A Strong Buy Due To Execution In Oncology (NASDAQ:JAZZ)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOOV9sRVhraUlhREg0aUF6OWRnd3A0bVNqc3l5NEJjMGM5N2pIb1Brb3c5ZU1CalJMdVJ5SGZ5VmJ6ZllXeHo0d01mVGQ5VHllVUpQMFpaUFE2UVJWOUh2eEZJbzV3WW9aYmxuU0h6U0l6LVMyc05LcTBIa2ZFQWN4eDRoZkFpTXJMaXZtaHdnQ3M4WTFqaTdjVlNMMEpoeGFfOXBHcDZCZ3NFdVRjVXpFM2s2RVdZQksyVHpUWFpzRmY?oc=5","date":"2026-01-08","type":"pipeline","source":"prnewswire.com","summary":"Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer - prnewswire.com","headline":"Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOenU4andVSU9tMnpINVdCaW1oaUdraDlmbm5YZVhHZmt0MnNkWElwTXp1LVQ3VFFpa0duMHd6NXNqMFhzRmxoSTdtbXd5Q1VFOVhqZ1NEMzMxWjZoUEk0SDFIbUd6OXFqcUpUTVhTVGQ5bms0Q2pYLVd6OG9BUGRXTmNuZ2kzdlRMNGc?oc=5","date":"2026-01-07","type":"trial","source":"The Pharma Letter","summary":"Jazz data not music to investors’ ears - The Pharma Letter","headline":"Jazz data not music to investors’ ears","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxONVdXa09sRjU0V2RpSEhoVHMyZWlYN3RfRnQxMWd0ZEJqNUZpNENpSlZEWjVuR2p2TE1KaXNPNWRWVGJsSkVYZllWMWIteGFWMDFEQWFmZE5EeklsZVM5VEw5enFmR0NYd0xuUXdtRmU4d1phcjZaVWlnd2R0MkxIQ0EyblFRZ1RYU2hGUWZSQXFIUEhVcGlaYl9Vbw?oc=5","date":"2025-11-17","type":"pipeline","source":"Barron's","summary":"Fed Minutes Arrive With Oil Prices Rising and Rate Path in Question - Barron's","headline":"Fed Minutes Arrive With Oil Prices Rising and Rate Path in Question - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQTzVhOHlVZEI0OE9XTWMwV1RlNlpUVlkwX3doTUJMZXh0WEtFSzFaeTJ3WmpQYVNGTmhTRno4djhmMGFKMTVDZzFsQzN1SWpFUm1qZHVHSnBXZG9VdVpJY29YaXUzN09XTmlLWTU2RkdCUkhnOEN5bU1aNXlHak1WT3FaZmV0U3hnc1h6VjlMWWh0RWc?oc=5","date":"2025-11-03","type":"deal","source":"PharmaTimes","summary":"CNX Therapeutics acquires Sativex from Jazz Pharmaceuticals - PharmaTimes","headline":"CNX Therapeutics acquires Sativex from Jazz Pharmaceuticals","sentiment":"neutral"}],"patents":[{"drugName":"Clozaril","drugSlug":"clozapine","patentNumber":"8057811","type":"Formulation","expiryDate":"2028-05-01","territory":"US","genericFilings":[]}],"drugCount":10,"phaseCounts":{"discontinued":2,"marketed":7,"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}